Previous close | 210.50 |
Open | 210.40 |
Bid | 213.50 x 0 |
Ask | 214.30 x 0 |
Day's range | 209.90 - 210.40 |
52-week range | 148.70 - 217.80 |
Volume | |
Avg. volume | 0 |
Market cap | N/A |
Beta (5Y monthly) | N/A |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Ingevity (NGVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Surmodics (SRDX) enters a definitive agreement to be acquired by renowned private equity company GTCR at an estimated total equity valuation of $627 million.
Investors are optimistic about DaVita's (DVA) strength in kidney care.